Sponsor or institution

Clinical trials and research at Chiome Bioscience Inc.

• 2Clinical trials
• 1Country

All recruiting trials (2)

• CBA-1535 (5T4/CD3) T‑cell engager given alone and with pembrolizumab for advanced solid tumors

  This trial tests whether CBA-1535, a T‑cell engager that targets 5T4, is safe and shows early signs of benefit when given alone or with pembrolizumab to people with advanced solid tumors who have no standard treatment options.

  Recruiting at 2 sites Phase 1 Chiome Bioscience Inc. · Nagaizumicho, Shizuoka and 1 other locations · NCT07016997

• Testing a new antibody treatment for advanced solid tumors and liver cancer

  This study is testing a new antibody treatment for people with advanced solid tumors and liver cancer to see if it is safe and how well it works.

  Recruiting at 5 sites Phase 1 Chiome Bioscience Inc. · Kashiwa, Chiba and 4 other locations · NCT06636435

Quick answers

How many clinical trials run by Chiome Bioscience Inc. are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in Japan. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →